{"id":"W4408555231","doi":"10.1055/s-0045-1804654","title":"Efficacy and Safety of Olomorasib with Pembrolizumab+Chemotherapy as First Line Treatment in Patients with KRAS G12C-Mutant Advanced NSCLC","year":2025,"lang":"en","type":"article","venue":"Pneumologie","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Occupational Cancer Research Centre; Alberta Health Services","funders":"","keywords":"Pembrolizumab; KRAS; Medicine; Chemotherapy; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006053507,0.0003171878,0.001162724,0.0002482133,0.0002420465,0.0005772735,0.0002312505,0.0004159543,0.001411011],"category_scores_gemma":[0.0008099747,0.000156288,0.0008956267,0.0002219535,0.000255396,0.0007177678,0.0001929221,0.001296154,0.0002609355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005655786,"about_ca_system_score_gemma":0.0005892377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006680707,"about_ca_topic_score_gemma":0.001855773,"domain_scores_codex":[0.9997128,0.00009648936,0.00002239429,0.000061168,0.00003265443,0.00007449211],"domain_scores_gemma":[0.9997212,0.00007828319,0.00005379401,0.00001933916,0.00001823161,0.0001091824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4990498,0.008764879,0.06207268,0.0008124929,0.002125365,0.0004242606,0.0001970838,0.003959397,0.03135354,0.0003027624,0.002537309,0.3884004],"study_design_scores_gemma":[0.084535,0.3812317,0.485938,0.0003617504,0.006690226,0.001935861,0.0003795575,0.009327085,0.01463654,0.0008097073,0.01402184,0.0001327278],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933827,0.004649587,0.0000969248,0.0002289964,0.00008018981,0.00005157062,0.0002237252,0.00001696001,0.001269353],"genre_scores_gemma":[0.9980629,0.000806703,0.0001242395,0.0001850102,0.00006418898,0.00003898604,0.0003284371,0.000003422329,0.0003859407],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001411011,"threshold_uncertainty_score":0.00472033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009384943681118335,"score_gpt":0.2713957310259564,"score_spread":0.2620107873448381,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}